Alkermes reports encouraging data from Phase III study of Lumryz

​Alkermes has reported positive top line data from the Phase III REVITALYZ study, assessing the investigational use of extended-release Lumryz oral suspension in adults with IH.

The post Alkermes reports encouraging data from Phase III study of Lumryz appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.